Corgi All World 2x Daily ETF(WX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WX Corgi All World 2x Daily ETF

盘前交易 11-12 09:01:51 EST

23.24

+0.50

+2.20%

最高23.24	最低23.24	成交量23.00
今开22.74	昨收22.74	日振幅0.00%
总市值46.49万	流通市值46.49万	总股本2.00万
成交额555.00	换手率0.11%	流通股本2.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":23.2439,"timestamp":1794430800000,"preClose":22.7443,"halted":0,"volume":23,"delay":0,"changeRate":0.021965943115417972,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"盘前交易","change":0.4996,"latestTime":"11-12 09:01:51 EST","open":22.7443,"high":23.2439,"low":23.2439,"amount":555,"amplitude":0,"askPrice":37.19,"askSize":200,"bidPrice":13.72,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794493800000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":23.2439,"nav":22.71,"aum":454200,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":22.7443,"preClose":23.2439,"latestTime":"16:10 EST","volume":6,"amount":139.4634,"timestamp":1794431408838,"change":-0.4996,"changeRate":-0.021494,"amplitude":0},"volumeRatio":0.19591118034441865},"requestUrl":"/m/hq/s/WX","defaultTab":"news","newsList":[{"id":"2682820601","title":"生物医药板块走强 再鼎医药（09688）涨超13% 全球医药融资回暖支撑创新药与CXO景气上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2682820601","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682820601?lang=zh_cn&edition=full","pubTime":"2026-11-09 10:08","pubTimestamp":1794190084,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走强，截至发稿，再鼎医药 涨13.07%，康诺亚-B涨7.22%，康方生物涨6.33%，科伦博泰生物涨5.36%，药明生物涨4.96%，金斯瑞生物科技涨4.48%，复宏汉霖涨4.04%。2026年上半年，全球生物科技融资、License交易、并购交易金额分别达到502亿美元、1667亿美元和960亿美元，均显著超越去年上半年，医药融资及License交易持续回暖，为医药研发提供了资金支持。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995489","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","BK1588","LU0359201612.USD","LU1242518931.SGD","LU0051755006.USD","MEDX","09688","LU0320764243.SGD","BK4581","LU1242518857.USD","159938","HK0000165453.HKD","LU0181495838.USD","LU0348784397.USD","06990","LU0029874061.USD","IBBQ","LU1794554557.SGD","02162","159992","LU2039709279.SGD","ZLAB","09939","LU2476274308.USD","06978","01548","02696","LNGR","CXO","LU0348767384.USD","399441","LU0348825331.USD","BK1610","LU0543330566.HKD","09926","KURE","BK4588","LU0561508036.HKD","XBI","161726","LU0516423091.SGD","LU0196878994.USD","BK1574","LU0456827905.SGD","WX","LU0140636845.USD","02269","LU0456846285.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681885217","title":"多家公司在手订单充裕，CXO行业景气度有望延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2681885217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681885217?lang=zh_cn&edition=full","pubTime":"2026-11-06 06:42","pubTimestamp":1793918546,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WX","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681408500","title":"中国CXO的暗战，前移到了“种子轮”","url":"https://stock-news.laohu8.com/highlight/detail?id=2681408500","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681408500?lang=zh_cn&edition=full","pubTime":"2026-11-05 17:45","pubTimestamp":1793871931,"startTime":"0","endTime":"0","summary":"文｜锦缎2026年，一家做动物试验的公司，开始往种子轮里投钱。昭衍新药，国内非临床安全性评价领域的主要玩家之一。2021年之前，中国创新药的研发投入一年一个台阶，CXO的产能排到两年后，谁扩产谁赚钱，订单排到哪一年都能卖出去。这是这一轮CXO资本化最朴素的动机。2026年三季度，泰格医药扣非净利润4.5亿元，归母净利润却是亏损2.72亿元。过去CXO只赌一件事：能不能接到单。而CXO的根，终究是产能、交付和客户信任。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1793848574267334958","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["WX","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681041611","title":"CRO涨停潮的资金面拆解：公募Q3持仓占比36.9%，21.97倍PE处于七年13%分位","url":"https://stock-news.laohu8.com/highlight/detail?id=2681041611","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681041611?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:23","pubTimestamp":1793866980,"startTime":"0","endTime":"0","summary":"11月4日上午，创新药与CXO方向再度拉升，药明生物、药明康德、百济神州涨幅居前，康龙化成、信达生物、瀚森制药等权重股同步活跃。盘面呈现的并非单一细分赛道的孤立行情，而是从CXO龙头向 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261105/c681506154.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261105/c681506154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX","IBBQ","06978","LNGR","BK1161","BK1574","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680519700","title":"CXO板块逆市走强 百济神州（06160）涨5.14%、凯莱英（06821）涨4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680519700","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680519700?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:34","pubTimestamp":1793759693,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块逆市走强，百济神州 涨5.14%，凯莱英涨4.19%，药明康德涨3.92%，药明生物涨3.58%，科伦博泰生物涨2.89%，药明合联涨2.44%，和铂医药-B涨1.76%，康龙化成涨1.46%，和黄医药涨1.17%。湘财证券表示，CXO龙头药明康德三季报超预期、指引上修，印证CXO由周期修复转向CRDMO结构性重估。维持药品行业“买入”评级，建议关注创新化学制剂及创新药产业链上游CXO公司。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995187","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","CXO","LU0588546209.SGD","LU1719994722.HKD","LU0128522744.USD","LU3063872942.SGD","02269","LU0501845795.SGD","002821","03759","LU0229945570.USD","LU0516423091.SGD","LU0326950275.SGD","LU0043850808.USD","LU0320764243.SGD","LU0072913022.USD","BK1141","LU0823426480.USD","LU0128526141.USD","LU0456827905.SGD","06160","KURE","688235","LU0455707207.USD","ONC","02268","06821","LU0516422440.USD","LU0828237510.HKD","BK0132","LU2476274720.SGD","06990","LU0051755006.USD","BK1574","00013","02142","LU0359202008.SGD","WX","LU2476274308.USD","LU0823426308.USD","LU1831875114.USD","LU1720050803.USD","LU2045819591.USD","SG9999002463.SGD","LU0327786744.USD","LU1242518857.USD","LU0502904849.HKD","02359","SG9999002562.SGD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680074627","title":"港股医药再突围！百济神州绩前领跑6%，CXO龙头反攻！创新药链核心工具520880、159137标的指数逆市涨逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680074627","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680074627?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:17","pubTimestamp":1793758620,"startTime":"0","endTime":"0","summary":"创新药及产业链全线拉涨：创新药龙头股领衔涨势，百济神州一度领涨超6%，荣昌生物、康方生物涨超4%；CXO同样强势，凯莱英涨近7%，药明生物、药明康德双双涨超4%。创新药纯度100%的恒生港股通创新药精选指数、高CXO含量港股通医疗主题指数携手涨超2%，跟踪指数的港股通创新药ETF华宝、港股通医疗ETF华宝同步走强。港股通创新药ETF华宝、港股通医疗ETF华宝标的指数市盈率估值分别为29.86倍、31倍，处于近3年维度16.67%、50%分位点。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-11-04/doc-inixprpe1740509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","BK1161","BK4585","LU0307460666.USD","BK1574","LU1251922891.USD","159137","CXO","LU1303224171.USD","KURE","520880","LU1719994722.HKD","LU0228659784.USD","ONC","06978","BK4588","LNGR","LU2328871848.SGD","06160","MEDX","688235","WX","BK0239","LU0828237510.HKD","BK1583","LU1969619763.USD","BK4139","BK1500","LU0588546209.SGD","BK4526","LU1770034418.SGD","IBBQ","BK1588","159718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679298366","title":"重仓股大换血！公募三季报收官，光模块高位减持，存储、CXO杀入前十","url":"https://stock-news.laohu8.com/highlight/detail?id=2679298366","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679298366?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:06","pubTimestamp":1793347610,"startTime":"0","endTime":"0","summary":"近三年主动权益基金业绩目前，公募基金2026年三季报披露收官，主动权益基金（积极投资股票基金、偏股混合基金、灵活配置混合基金）最新前十大重仓股随之出炉。天相投顾统计显示，相较二季度末，药明康德、长鑫科技、沪电股份新进前十大重仓股，兆易创新、中微公司、三环集团退出。增减持的天平明显倾斜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610303916512839.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610303916512839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LUMA","CXO","AAOG","AAOX","WX","AAOZ","LYTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679687672","title":"CXO捷报频传！高盛集体上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2679687672","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679687672?lang=zh_cn&edition=full","pubTime":"2026-10-30 11:55","pubTimestamp":1793332500,"startTime":"0","endTime":"0","summary":"多股业绩亮眼消息面上，三季报窗口，中国创新药与CXO两条主线频传捷报。高盛集体上调目标价10月15日，高盛在最新研报中将覆盖的七家公司12个月目标价全线上调，平均上调幅度约9%。内需CXO则呈现“订单先行、收入后至”的修复路径。两者共同决定本轮CXO复苏的持续性。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-10-30/doc-iniwyncz8325426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WX","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677935858","title":"港股CXO板块午后走低，昭衍新药跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677935858","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677935858?lang=zh_cn&edition=full","pubTime":"2026-10-22 13:10","pubTimestamp":1792645817,"startTime":"0","endTime":"0","summary":"10月22日，港股CXO板块午后走低，昭衍新药跌超10%，凯莱英跌近9%，药明生物、泰格医药、金斯瑞生物科技、药明康德跌超5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610223903905888.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610223903905888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KCAI","BK1576","BK4588","06127","603127","VXUS","BK1141","WX","CXO","BK4585","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677565933","title":"港股CXO概念股午后走弱，昭衍新药跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677565933","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677565933?lang=zh_cn&edition=full","pubTime":"2026-10-22 13:03","pubTimestamp":1792645436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCAI","WX","BK4585","VXUS","CXO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676666032","title":"ADC出海新纪录，翰森制药冲高9%，港股通创新药大受提振！CXO、互联网医疗齐升，港股通医疗ETF华宝爆量上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2676666032","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676666032?lang=zh_cn&edition=full","pubTime":"2026-10-20 19:08","pubTimestamp":1792494480,"startTime":"0","endTime":"0","summary":"A股医疗板块低开高走，迪安诊断20CM涨停，医疗ETF华宝收复半年线；创新药延续修复，药ETF华宝四连涨。港股大市调整，医药板块走出独立行情，创新药、CXO、互联网医疗等多点开花！港股通医疗ETF华宝、港股通创新药ETF华宝标的指数盘中分别上探3%、2.4%，收涨1.58%、1.49%。超155亿美元BD大单提振，翰森制药盘中暴拉逾9%，收涨8.32%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-20/doc-inivwpzm6468595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FLHK","CXO","06978","159992","BK1583","IBBQ","BK1191","512170","BK1589","LNGR","MEDX","BK1161","03692","WX","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676655678","title":"155亿美元！翰森制药再签罗氏，股价狂飙！药明系上演“纠错行情”，高CXO含量ETF（159137）标的指数摸高3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676655678","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676655678?lang=zh_cn&edition=full","pubTime":"2026-10-20 11:03","pubTimestamp":1792465380,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。CXO同步走强，药明生物领涨超6%，药明合联涨超2%。消息面，翰森制药10月19日发布公告，已与罗氏订立战略合作及授权协议。以药明系为代表的CXO强势反弹，或受益于“错杀”修复。捕捉港股医药高弹性机遇，关注两个T+0交易工具：港股通创新药ETF华宝：标的指数100%布局创新药研发类公司，7成仓位押注创新药研发龙头。港股通医疗ETF华宝：标的指数AI制药含量超73%，CXO含量近60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-20/doc-inivvsvv6616806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159137","BK1589","BK1583","CXO","BK4550","WX","BK1191","FDN","BK4585","03692","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676014658","title":"嘉实基金郝淼：创新药产业链景气度或持续向上，CXO受益内外需共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2676014658","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676014658?lang=zh_cn&edition=full","pubTime":"2026-10-20 10:00","pubTimestamp":1792461600,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。他预计2026全年，整个创新药产业链景气度或持续向上。中国创新药产业上游企业有望同时受益于内外需共振，仍有较大的成长空间。综合而言，郝淼预计，中国创新药产业全球化发展的新周期仍会持续，两三年后有望看到一批中国本土开发的创新药品种在全球实现商业化销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-10-20/doc-inivvsvr7584596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","159992","MEDX","BK1161","06978","BK1574","LNGR","CXO","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676508415","title":"午后突升，医疗ETF华宝、药ETF华宝携手走强！CXO强势反弹，康龙化成冲涨8%！中药股获追捧，达仁堂涨停封板","url":"https://stock-news.laohu8.com/highlight/detail?id=2676508415","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676508415?lang=zh_cn&edition=full","pubTime":"2026-10-19 14:25","pubTimestamp":1792391100,"startTime":"0","endTime":"0","summary":"CXO龙头领涨，康龙化成涨超8%，凯莱英涨超4%；医械股同步活跃，新产业涨近6%。制药板块午后亦启动，中药股强势，达仁堂涨停封板！分析指出，本次征求意见稿较草案口径收窄，创新药授权出海不受限制，且对CXO企业经营无影响，持续看好中国创新药及产业链在全球范围内影响力提升，行业景气度维持上行。药ETF华宝及其联接基金、医疗ETF华宝的风险等级为R3-中风险，适宜平衡型及以上的投资者。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-19/doc-inivtuen0898075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0239","562050","300759","BK0060","03759","512170","WX","BK0164","600329","BK1141","BK0188","BK1576","CXO","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676576180","title":"华泰证券港股策略：红利继续做底仓 可阶段性重点关注创新药及CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2676576180","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676576180?lang=zh_cn&edition=full","pubTime":"2026-10-19 07:54","pubTimestamp":1792367659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","CXO","VXUS","MEDX","LNGR","KCAI","WX","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676521071","title":"医药内部也不是一条赛道：大药企、创新药与CXO为何不能用同一套轮动逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2676521071","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676521071?lang=zh_cn&edition=full","pubTime":"2026-10-18 16:18","pubTimestamp":1792311480,"startTime":"0","endTime":"0","summary":"礼来、AbbVie等制药巨头股价走强，容易被概括为“资金从AI转向医药”。但股价接近高位，不等于资金已经系统性迁移：现有公开线索没有提供相关个股的具体涨幅区间、指数资金流、ETF申赎或全 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261018/c680806232.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261018/c680806232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["WX","09939","BK1515","MEDX","06978","CXO","159938","159992","BK1574","LNGR","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676237815","title":"AI热度与医药行情并非跷跷板：从研发投入看CXO的传导链条","url":"https://stock-news.laohu8.com/highlight/detail?id=2676237815","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676237815?lang=zh_cn&edition=full","pubTime":"2026-10-18 08:18","pubTimestamp":1792282680,"startTime":"0","endTime":"0","summary":"礼来、AbbVie等制药巨头股价走强，市场很容易把行情概括为“资金从AI转向医药”。但股价靠近高位，和资金正在系统性撤离AI，是两回事。现有公开线索没有提供相关个股的具体涨幅区间、指数资 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261018/c680804804.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261018/c680804804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1515","WX","CHAT","BK1574","AIPO","ARTY","159938","BK1161","AGIX","VTHR","QTOC","09939","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675094370","title":"南方港股医药三季报解码，减权益、加CXO，资金在押注什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2675094370","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675094370?lang=zh_cn&edition=full","pubTime":"2026-10-15 13:05","pubTimestamp":1792040700,"startTime":"0","endTime":"0","summary":"一、净值与份额同步增长，权益占比下降10月13日，南方港股医药行业混合基金率先披露2026年公募基金行业首份三季报，基金经理对医药行业的最新观点随之出炉。得益于三季度港股医药板块(如恒 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261015/c680723687.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261015/c680723687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["KURE","CXO","159718","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675381393","title":"港股CXO概念股盘初下挫，金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675381393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675381393?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:34","pubTimestamp":1791855288,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","WX","KCAI","VXUS","BK4585","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674892318","title":"【券商聚焦】中泰国际：多家药企将公布重要数据 推荐创新药与CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2674892318","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674892318?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:38","pubTimestamp":1791506310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际表示，多家创新药企业将于10月下旬ESMO公布重要临床数据。ESMO是欧洲最具盛名和影响力的肿瘤学会议，LBA是最高级别的研究成果展示，因此ESMO公布的LBA在医药行业广受关注。中国企业入选的LBA中，有四项入选最高级别的主席研讨会。该机构认为，以上情况表明中国创新药研发能力在海外广受认可，因此创新药板块值得继续关注。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","06821","06160","02268","LU2097828714.EUR","01093","LU0348827113.USD","00013","SG9999002463.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP","01177","LU1008478684.HKD","LU0327786744.USD","IBBQ","LU0348767384.USD","LU1831875114.USD","LU0320764599.SGD","LU0348783233.USD","LU0149534421.HKD","06978","LU0307460666.USD","02359","LU0561508036.HKD","LU1960683339.HKD","KURE","IE0008369823.USD","LU0067412154.USD","MEDX","LU0823426308.USD","LNGR","LU1688375341.USD","LU2125910500.SGD","LU1242518931.SGD","WX","BK1521","CXO","LU0029874905.USD","LU0708995153.HKD","BK1500","LU2097828557.USD","LU2488822045.USD","01801","LU2399975544.HKD","159992","KCE","BK1191","09926","IE00B5MMRT66.SGD","02269"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.wuxiapptec.com","stockEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0467},{"period":"3month","weight":-0.0908},{"period":"6month","weight":-0.0597},{"period":"ytd","weight":-0.0597}],"compareEarnings":[{"period":"1week","weight":-0.0091},{"period":"1month","weight":-0.0235},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.0279},{"period":"1year","weight":0.1125},{"period":"ytd","weight":0.1142}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"药明康德在开曼群岛注册成立于2004年6月3日，没有显著的资产或它自己的业务。几乎所有在中国开展的业务都是通过其主要运营子公司，WXAT，一家于2000年12月成立的药明康德新药开发有限公司。公司的核心业务是提供发现化学服务在药物发现过程的开始合成的小分子。该公司是一家全球领先的制药、生物技术以及医疗器械研发外包服务公司。公司的核心业务是在药物发展过程的开始阶段为合成小分子提供发现化学服务。公司主要在中国和美国经营业务。公司在研发过程中提供一系列全方位的实验室及制造服务给客户，这些客户包括许多世界一流的制药、生物技术和医疗器械公司。公司的服务旨在帮助全球客户缩短时间，并通过提供具有成本效益和高效率的外包解决方案，降低药品和医疗器械的研发成本。","exchange":"CBOE","name":"Corgi All World 2x Daily ETF","nameEN":"Corgi All World 2x Daily ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corgi All World 2x Daily ETF(WX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corgi All World 2x Daily ETF(WX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corgi All World 2x Daily ETF,WX,Corgi All World 2x Daily ETF股票,Corgi All World 2x Daily ETF股票老虎,Corgi All World 2x Daily ETF股票老虎国际,Corgi All World 2x Daily ETF行情,Corgi All World 2x Daily ETF股票行情,Corgi All World 2x Daily ETF股价,Corgi All World 2x Daily ETF股市,Corgi All World 2x Daily ETF股票价格,Corgi All World 2x Daily ETF股票交易,Corgi All World 2x Daily ETF股票购买,Corgi All World 2x Daily ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corgi All World 2x Daily ETF(WX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corgi All World 2x Daily ETF(WX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}